Study questions benefit of new Alzheimer's drug
Cost, time burden and side effects may not be worth the minimal benefit.
Source: uga.edu
Stay updated with breaking news from Henryc Barry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cost, time burden and side effects may not be worth the minimal benefit.
The effectiveness of a new drug used to treat Alzheimer’s was called into question by a recent University of Georgia study, according to a Jan. 22 press release.